Get started
Author

Xiangcai Wang

Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer
2018 · Xinqiang Wu, Yuanbing Wu, et al. · Journal of Cancer · 250
PDF
Lactate: The Mediator of Metabolism and Immunosuppression
2022 · Yuanyuan Zhang, Zhao Zhai, et al. · Frontiers in Endocrinology · 114
PDF
The anticancer functions of RIG-I–like receptors, RIG-I and MDA5, and their applications in cancer therapy
2017 · Yuanbing Wu, Xinqiang Wu, et al. · Translational research · 97
TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2
2020 · Zheng Guo, Xiufang Zhang, et al. · Oncology Reports · 93
PDF
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors
2023 · Yuanyuan Zhao, Yuxiang Ma, et al. · Journal of Hematology & Oncology · 72
PDF
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
2025 · Yinghong Shi, Guohong Han, et al. · The Lancet. Gastroenterology & hepatology · 67
Machine learning models for predicting metabolic dysfunction-associated steatotic liver disease prevalence using basic demographic and clinical characteristics
2025 · Gangfeng Zhu, Yipeng Song, et al. · Journal of Translational Medicine · 55
Tripartite motif‐containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin‐proteasome–mediated degradation of pleckstrin homology domain leucine‐rich repeats protein phosphatase 1
2021 · Juan Yang, Jianming Ye, et al. · Hepatology · 26
Efficacy and safety of pralsetinib in patients with advanced RET fusion‐positive non–small cell lung cancer
2023 · Qing Zhou, Jun Zhao, et al. · Cancer · 24
PDF
Tumor Grade and Overall Survival Prediction of Gliomas Using Radiomics
2021 · Jianming Ye, He Huang, et al. · Scientific Programming · 11
PDF
Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial
2023 · Huiping Li, Yan Huang, et al. · BioDrugs · 10
PDF
MMP9 Expression Correlates With Cisplatin Resistance in Small Cell Lung Cancer Patients
2022 · Longqiu Wu, Xiangcai Wang, et al. · Frontiers in Pharmacology · 10
PDF
Efficacy and safety of KN026 in combination with KN046 in patients with locally advanced unresectable or metastatic HER2-positive other solid tumors.
2023 · Jifang Gong, Lei Chen, et al. · Journal of Clinical Oncology · 9
Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma
2022 · Rongrong Liu, Weidong Liang, et al. · Frontiers in Immunology · 9
Safety and Efficacy of KN046 in Combination with KN026 in Patients with Advanced HER2-Positive Breast Cancer: A Phase II Trial
2025 · Jieqiong Liu, Chuangui Song, et al. · Clinical Cancer Research · 8
PDF
Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K / AKT signaling pathway
2023 · Mingchun Li, Zhihua Liu, et al. · Thoracic Cancer · 8
PDF
The efficacy and safety of conventional transcatheter arterial chemoembolization combined with PD-1 inhibitor and anti-angiogenesis tyrosine kinase inhibitor treatment for patients with unresectable hepatocellular carcinoma: a real-world comparative study
2022 · Zheng Guo, Huabin Zhu, et al. · Frontiers in Oncology · 8
OTO-Net: An Automated MRA Image Segmentation Network for Intracranial Aneurysms
2022 · Jianming Ye, Xiaomei Xu, et al. · Computational Intelligence and Neuroscience · 7
PDF
Automated Segmentation of Mass Regions in DBT Images Using a Dilated DCNN Approach
2022 · Jianming Ye, Weiji Yang, et al. · Computational Intelligence and Neuroscience · 7
PDF
Peripheral blood inflammation indices are effective predictors of anastomotic leakage in elective esophageal surgery
2021 · Cai-Xia Wu, Ding-Yu Rao, et al. · Journal of Gastrointestinal Oncology · 7
PDF
Promising early results of MHB088C (B7-H3 ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) from a phase 1/2 multicenter study.
2025 · Lin Shen, Xue Meng, et al. · Journal of Clinical Oncology · 5
PDF
Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation
2024 · Li Huang, Xiaoting Zhong, et al. · Cancer Cell International · 5
Circ‐DTL sponges miR‐758‐3p to accelerate cervical cancer malignant progression by regulating DCUN1D1 expression
2023 · Xiaoning Luo, Jiewen Liu, et al. · Journal of Biochemical and Molecular Toxicology · 5
USP38: an important regulatory factor in tumor malignant progression
2025 · Junyan Li, Jinghua Zhong, et al. · Frontiers in Immunology · 4
PDF
USP39: a key regulator in malignant tumor progression
2025 · Junyan Li, Jinghua Zhong, et al. · Frontiers in Oncology · 4
PDF
Works count: 55
Citation count: 938
H-index: 10
I10-index: 12
Year
Topic
Type